These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 17475843)

  • 1. Regulation by Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 of alpha-galactosylceramide-induced antimetastatic activity and Th1 and Th2 responses of NKT cells.
    Okajo J; Kaneko Y; Murata Y; Tomizawa T; Okuzawa C; Saito Y; Kaneko Y; Ishikawa-Sekigami T; Okazawa H; Ohnishi H; Matozaki T; Nojima Y
    J Immunol; 2007 May; 178(10):6164-72. PubMed ID: 17475843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced suppression of pulmonary metastasis of malignant melanoma cells by combined administration of alpha-galactosylceramide and interleukin-18.
    Nishio S; Yamada N; Ohyama H; Yamanegi K; Nakasho K; Hata M; Nakamura Y; Fukunaga S; Futani H; Yoshiya S; Ueda H; Taniguchi M; Okamura H; Terada N
    Cancer Sci; 2008 Jan; 99(1):113-20. PubMed ID: 17949451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Killing activity of human umbilical cord blood-derived TCRValpha24(+) NKT cells against normal and malignant hematological cells in vitro: a comparative study with NK cells or OKT3 activated T lymphocytes or with adult peripheral blood NKT cells.
    Hagihara M; Gansuvd B; Ueda Y; Tsuchiya T; Masui A; Tazume K; Inoue H; Kato S; Hotta T
    Cancer Immunol Immunother; 2002 Mar; 51(1):1-8. PubMed ID: 11845254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of alphaGalCer-induced TCRValpha24 Vbeta11(+) natural killer T cells on NK cell cytotoxicity in umbilical cord blood.
    Ueda Y; Hagihara M; Gansuvd B; Yu Y; Masui A; Okamoto A; Higuchi A; Tazume K; Kato S; Hotta T
    Cancer Immunol Immunother; 2003 Oct; 52(10):625-31. PubMed ID: 12802518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer T cells from interleukin-4-deficient mice are defective in early interferon-gamma production in response to alpha-galactosylceramide.
    Togashi Y; Chamoto K; Wakita D; Tsutsumi N; Iwakura Y; Matsubara N; Kitamura H; Nishimura T
    Cancer Sci; 2007 May; 98(5):721-5. PubMed ID: 17359285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent immune-modulating and anticancer effects of NKT cell stimulatory glycolipids.
    Chang YJ; Huang JR; Tsai YC; Hung JT; Wu D; Fujio M; Wong CH; Yu AL
    Proc Natl Acad Sci U S A; 2007 Jun; 104(25):10299-304. PubMed ID: 17566107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effect of alpha-galactosylceramide-loaded dendritic cells genetically engineered to express SLC/CCL21 along with tumor antigen against peritoneally disseminated tumor cells.
    Matsuyoshi H; Hirata S; Yoshitake Y; Motomura Y; Fukuma D; Kurisaki A; Nakatsura T; Nishimura Y; Senju S
    Cancer Sci; 2005 Dec; 96(12):889-96. PubMed ID: 16367909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural killer T cell-mediated antitumor immune responses and their clinical applications.
    Seino K; Motohashi S; Fujisawa T; Nakayama T; Taniguchi M
    Cancer Sci; 2006 Sep; 97(9):807-12. PubMed ID: 16805854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Designed
    Ma J; He P; Zhao C; Ren Q; Dong Z; Qiu J; Jing Y; Liu S; Du Y
    Adv Sci (Weinh); 2020 Jul; 7(14):2000609. PubMed ID: 32714765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective presentation of the CD1d1-restricted natural Va14Ja18 NKT lymphocyte antigen caused by beta-D-glucosylceramide synthase deficiency.
    Stanic AK; De Silva AD; Park JJ; Sriram V; Ichikawa S; Hirabyashi Y; Hayakawa K; Van Kaer L; Brutkiewicz RR; Joyce S
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):1849-54. PubMed ID: 12576547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor.
    Zajonc DM; Cantu C; Mattner J; Zhou D; Savage PB; Bendelac A; Wilson IA; Teyton L
    Nat Immunol; 2005 Aug; 6(8):810-8. PubMed ID: 16007091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of lipids obtained from γ-irradiated PBMCs in dendritic cell-mediated skin inflammation.
    Laggner M; Copic D; Nemec L; Vorstandlechner V; Gugerell A; Gruber F; Peterbauer A; Ankersmit HJ; Mildner M
    EBioMedicine; 2020 May; 55():102774. PubMed ID: 32403085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberous sclerosis 1 promotes invariant NKT cell anergy and inhibits invariant NKT cell-mediated antitumor immunity.
    Wu J; Shin J; Xie D; Wang H; Gao J; Zhong XP
    J Immunol; 2014 Mar; 192(6):2643-50. PubMed ID: 24532578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase I study of alpha-galactosylceramide-pulsed antigen presenting cells administration to the nasal submucosa in unresectable or recurrent head and neck cancer.
    Uchida T; Horiguchi S; Tanaka Y; Yamamoto H; Kunii N; Motohashi S; Taniguchi M; Nakayama T; Okamoto Y
    Cancer Immunol Immunother; 2008 Mar; 57(3):337-45. PubMed ID: 17690880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of chitinase-3-like-1 in T cell elicits Th1 and cytotoxic responses to inhibit lung metastasis.
    Kim DH; Park HJ; Lim S; Koo JH; Lee HG; Choi JO; Oh JH; Ha SJ; Kang MJ; Lee CM; Lee CG; Elias JA; Choi JM
    Nat Commun; 2018 Feb; 9(1):503. PubMed ID: 29403003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutting edge: genetic characterization of IFN-producing killer dendritic cells.
    Guimont-Desrochers F; Cappello ZJ; Chagnon M; McDuffie M; Lesage S
    J Immunol; 2009 May; 182(9):5193-7. PubMed ID: 19380763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target.
    Barclay AN; Van den Berg TK
    Annu Rev Immunol; 2014; 32():25-50. PubMed ID: 24215318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting of SIRPα as a potential therapy for Langerhans cell histiocytosis.
    Okamoto T; Murata Y; Hasegawa D; Yoshida M; Tanaka D; Ueda T; Hazama D; Oduori OS; Komori S; Takai T; Saito Y; Kotani T; Kosaka Y; Maniwa Y; Matozaki T
    Cancer Sci; 2023 May; 114(5):1871-1881. PubMed ID: 36788737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD47 Deficiency Ameliorates Ocular Autoimmune Inflammation.
    Okunuki Y; Tabor SJ; Lee MY; Connor KM
    Front Immunol; 2021; 12():680568. PubMed ID: 34093583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials.
    Zhang Y; Springfield R; Chen S; Li X; Feng X; Moshirian R; Yang R; Yuan W
    Front Immunol; 2019; 10():1126. PubMed ID: 31244823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.